Childhood neuroblastoma is curable if it is early stage, low risk and responds well to medications. However, if the treatment effect is poor or if the tumor is advanced and high risk, the cure rate is lower.
1. Early low-risk: Since the response of neuroblastoma to drugs varies greatly during treatment, children with early onset or low-risk differentiation neuroblastoma have a better curative effect and better prognosis with a higher survival rate. Early surgical resection and regular checkups can quickly cure neuroblastoma.
2. Advanced high-risk: If the differentiation of neuroblastoma is highly malignant or insensitive to therapeutic drugs, the tumor may continue to grow and enter the advanced stage, which has little chance of cure and low survival rate. Meanwhile, because advanced neuroblastoma may have distant metastasis, the difficulty of treatment will gradually increase.
Children with neuroblastoma should undergo pathologic examination and surgical resection as soon as possible. Meanwhile, after the first treatment, regular checkups are needed to avoid recurrence or metastasis.